Similar Search Results

Chapter Twelve. Markets for Pharmaceutical Products

Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011

This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …

Persistent link: https://www.econbiz.de/10014025576

The effect of regulated competition on pharmaceutical advertising and promotion

David, Guy; Markowitz, Sara - In: Eastern economic journal 41 (2015) 1, pp. 24-39

Persistent link: https://www.econbiz.de/10010489493

Drug Pricing in a Regulated Market

Capri, Stefano; Levaggi, Rosella - 2004

In this article we analyse the problem of determining the price for new drugs in a market where a stringent budget constraint on public expenditure exists and we suggest an innovative methodology to set their prices. The market is characterised by asymmetry of information and a high proportion...

Persistent link: https://www.econbiz.de/10014071880

Pharmaceutical Patents : Incentives for R&D or Marketing?

Brekke, Kurt Richard; Straume, Odd Rune - 2021

We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R … industry. Within a fairly general model framework, we derive exact conditions for advertising and R&D being substitute … strategies for the incumbent firm and show that it may overinvest in advertising to reduce the incentive for an entrant to invest …

Persistent link: https://www.econbiz.de/10013316463

Entry into New Pharmaceutical Submarkets : The Role of Submarket Concentration

Amisano, Gianni - 2014

Using a reduced form binary econometric model, we analyze the determinants of pharmaceutical companies entry decisions into new submarkets. Our sample includes data for pharmaceutical companies over the period 1987-1998 for seven countries. Estimation is done both at the aggregate level and at a...

Persistent link: https://www.econbiz.de/10012708979

Advertising regulations in pharmaceutical markets : product versus enlightenment

Ishida, Junichiro; Takahara, Tsuyoshi - 2019

This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical market, with particular focus on the distinction between product and enlightenment advertisement. Firms are allowed to freely promote their own specific products under product DTCA,...

Persistent link: https://www.econbiz.de/10012024745

The Effect of Price Caps on Pharmaceutical Advertising : Evidence from the 340b Drug Pricing Program

Hristakeva, Sylvia; Mortimer, Julie Holland; Yde, Eric - National Bureau of Economic Research - 2024

We study the effect of price caps on the provision of costly effort by pharmaceutical firms using variation in drug discounts generated by a price regulation program that allows eligible hospitals to purchase outpatient drugs at steep discounts. These discounts directly affect drug...

Persistent link: https://www.econbiz.de/10014512103

Advertising Regulations in Pharmaceutical Markets : Product versus Enlightenment

Ishida, Junichiro - 2019

Persistent link: https://www.econbiz.de/10012897821

Pharmaceutical Promotion and Gp Prescription Behaviour

Windmeijer, Frank; de Laat, Eric; Douven, Rudy; Mot, Esther - 2006

The aim of this paper is to empirically analyse the responses by general practitioners to promotional activities for ethical drugs by pharmaceutical companies. Promotion can be beneficial as a means of providing information, but it can also be harmful in the sense that it lowers price...

Persistent link: https://www.econbiz.de/10014058923

Should product-specific advertisement be regulated in pharmaceutical markets?

Ishida, Junichiro; Takahara, Tsuyoshi - 2022

This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category-specific-and identifies a key tradeoff which underlies this policy debate. Our analysis suggests that the optimal form of DTCA depends crucially on the cost effectiveness of...

Persistent link: https://www.econbiz.de/10013329470

1
2
3
4
5
6
7
8
9
10
Next
Last